Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sundlof feels industry's NDI pain

This article was originally published in The Tan Sheet

Executive Summary

FDA's Center for Food Safety and Applied Nutrition currently rejects 80 percent of the new dietary ingredient notifications it receives "because industry doesn't really understand what we require," says center Director Stephen Sundlof. The NDI guidance is "still under review ... but we are pressing to get that out and we know that the industry really wants to have that guidance," Sundlof said at the Food and Drug Law Institute's annual conference April 22 in Washington. Supplement industry stakeholders have long said an NDI guidance would be a key incentive for developing new products, and Sundlof said he realizes publishing the guidance "would be really helpful" to industry. The recent switch by Sens. John McCain, R-Ariz., and Byron Dorgan, D-N.D., from sponsoring a bill that would put new burdens on the industry to backing legislation that requires FDA to complete the NDI notification guidance "as soon as possible" also could compel CFSAN's work (1"The Tan Sheet" March 15, 2010)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104049

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel